ICNEA 2710—Chemical pharmaceutical API manufacturing

Where 2710 sits

1. C Manufacturing industry
2. 27 Pharmaceutical manufacturing industry
3. 271 Chemical pharmaceutical API manufacturing
4. 2710 Chemical pharmaceutical API manufacturing

What 2710 includes

• Refers to the production activities of apis required for the further processing of chemical and pharmaceutical preparations and biological pharmaceutical preparations.
• Including the manufacturing activities of the following chemical pharmaceutical raw materials：
• Antibiotics (anti-infective drugs): penicillins, aminoglycosides, tetracyclines;
• Digestive system medicines: quaternary ammonium compounds, medicinal lactones, glycyrrhizates, aloe vera, and other digestive system medicines;
• Antipyretic analgesics: aspirin, salicylic acid and its salts, salicylates, containing non-fused pyrazole ring compounds, cyclic amides, sulfonylamines, ergotamines and their salts (antipyretic analgesics), Ibuprofen, other antipyretic analgesics;
• Vitamins: vitamin A original medicines, vitamin B original medicines, vitamin C original medicines, vitamin D or DL-pantothenic acid original medicines, vitamin E original medicines, multivitamin medicines, other vitamins and their derivatives;
• Antiparasitic drugs: quinine and its salts, chloroquines, piperazines, thiopyrimines, cinchona alkaloids, and other antiparasitic drugs;
• Central nervous system drugs: barbiturates, acylamides, caffeine, other central nervous system drugs;
• Family planning medication;
• Hormonal drugs: pituitary hormone drugs, adrenal corticosteroids, growth hormone analogs, glucuronolides, pancreatic hormones, estrogen and progesterone; other hormonal drugs;
• Antitumor drugs: mostins, methotrexate, purines, antitumor drugs of natural origin;
• Medicines for the cardiovascular system: glycosides, ergot alkaloids and their derivatives, as well as salts, Digoxin, quinidine, Lolul, and other medicines for the cardiovascular system;
• Respiratory system medicines: Guaiacol, Cresol sulfonic acids, Kalamefen, ephedrine, theophylline and aminophylline, natural glycosides;
• Urinary system medications: thiazides, theobromine, natural or synthetic glycosides, mercury, and other urinary system medications;
• Blood system medicines: heparin, coumarin, hydroxyl starch, other blood system medicines;
• Original medicines for diagnosis: pantothenic acid, glucamines, iodatalacic acid, other original medicines for diagnosis;
• Mediating water, electrolytes, acid-base balance drugs: glucose drugs, sugar ethers, sugar esters and their salts, chemically pure lactose, electrolyte balance regulating drugs, acid-base balance regulating drugs, dialysates, other mediating water, electrolytes, acid-base balance drugs;
• Narcotic drugs: choline, choline salts and derivatives, opiate, opiate derivatives and related salts, cocaine and its salts, other narcotic drugs;
• Antihistamines and detoxification drugs: antihistamines, detoxification drugs, radioisotope drugs, other antihistamines and detoxification drugs;
• Biochemical drugs (enzymes and coenzymes): lecithin and related phosphoramino lipids, amino acids and protein drugs (APIs), other biochemical drugs;
• Disinfection, anticorrosive and trauma surgery drugs: acridine drugs, chlorhexidine drugs, mercury drugs, spoilorectin, propionyl lactone, other disinfection, anticorrosive and trauma surgery drugs;
• Excipients and additives for preparations: gel products dedicated to human or veterinary drugs, lubricants dedicated to human or veterinary drugs, coupling agents dedicated to human or veterinary drugs, excipients and additives for other preparations;
• Antiviral drugs;
• Anti-drug resistant bacteria drugs;
• Anti-deep and multi-fungal drugs;
• Anti-drug resistant Mycobacterium tuberculosis drugs;
• Anti-other microbial drugs;
• Anti-chlamydial drugs;
• Anti-mycoplasma drugs;
• Antimalarial drugs;
• Antiparasitic drugs;
• Drugs for cardiovascular, endocrine and metabolic diseases (novel single and compound drugs for the prevention and treatment of cardiovascular and cerebrovascular diseases such as hypertension and the treatment of endocrine and metabolic diseases such as diabetes with novel mechanisms of action, long-acting and quick-acting, and convenient medication);
• Immunomodulatory agent for the treatment of rheumatoid arthritis;
• Systemic lupus erythematosus immunomodulator;
• Psoriasis immunomodulator;
• Gout immunomodulator;
• Immunomodulatory immunomodulatory agent;
• Immunomodulatory agent for transplant rejection response;
• New long-acting drugs for mental diseases;
• New long-acting drugs for Alzheimer's disease;
• New long-acting drugs for Parkinson's disease;
• New long-acting drugs for chronic neuropathic pain;
• New types of drugs for the treatment of childhood diseases and "orphan diseases" treatment drugs;
• Targeted drugs.

2710 in other systems